Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recipients of Allogeneic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05590091
What this trial is testing

Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients

Who this might be right for
Nutrition Aspect of CancerStem Cell Transplant Complications
Hebei Yanda Ludaopei Hospital 106
Not applicableStudy completedNCT03448471
What this trial is testing

Severe Fatigue in Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationFatigue
Gazi University 49
Testing effectiveness (Phase 2)Ended earlyNCT04762875
What this trial is testing

MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies

Who this might be right for
Related Donors Donating PBSC to a Family MemberHealthy DonorsAcute Myelogenous Leukemia+2 more
Ensoma 7
Testing effectiveness (Phase 2)Ended earlyNCT03720392
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)
Zachariah Michael DeFilipp 8
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03078010
What this trial is testing

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

Who this might be right for
Intestinal MicrobiomeFebrile Neutropenia
Memorial Sloan Kettering Cancer Center 347
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Early research (Phase 1)Active Not RecruitingNCT04013685
What this trial is testing

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more
Orca Biosystems, Inc. 155
Testing effectiveness (Phase 2)Study completedNCT04339062
What this trial is testing

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaAdvanced Cancer
Dana-Farber Cancer Institute 12
Not applicableStudy completedNCT02270346
What this trial is testing

Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Gazi University 40
Early research (Phase 1)Looking for participantsNCT03802695
What this trial is testing

Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMixed Phenotype Acute Leukemia+1 more
Orca Biosystems, Inc. 300
Very early researchStudy completedNCT00612274
What this trial is testing

Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplantation
Yale University 26
Testing effectiveness (Phase 2)Ended earlyNCT03339401
What this trial is testing

The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation

Who this might be right for
Adenovirus
Jazz Pharmaceuticals 29
Large-scale testing (Phase 3)Study completedNCT03565900
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 277
Not applicableStudy completedNCT04707417
What this trial is testing

Home Care in Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplant ComplicationsQuality of LifeGVH - Graft Versus Host Reaction
Oslo University Hospital 16
Not applicableStudy completedNCT01904175
What this trial is testing

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

Who this might be right for
Hodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more
Duke University 48
Testing effectiveness (Phase 2)Study completedNCT00285259
What this trial is testing

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more
Astellas Pharma Inc 112
Not applicableStudy completedNCT07049536
What this trial is testing

Physical Fitness of Allogeneic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
Istinye University 17
Early research (Phase 1)Active Not RecruitingNCT04177004
What this trial is testing

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 52
Early research (Phase 1)Active Not RecruitingNCT03922035
What this trial is testing

CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 36
Next Page